Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis (TMC207-CL001)

Mise à jour : Il y a 4 ans
Référence : NCT01215110

Femme et Homme

Extrait

The trial will evaluate the extended bactericidal activity of 14 consecutive days of oral administration of TMC207 at multiple doses as determined by the rate of change of log10 colony forming units (CFU) per ml sputum over the time period Day 7-14 in participants with smear positive pulmonary tuberculosis (TB). A control group will receive standard treatment.


Critère d'inclusion

  • Pulmonary tuberculosis

Liens